Clinical Trial Update: Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment. [Phase 2]

View source ↗

Summary

Phase II clinical trial investigating KL16-012 in women with fibromyalgia refractory to conventional treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Cannabis (Cannabis)
• KL16-012

Snippet

Sponsor: Knop Laboratorios | Conditions: Fibromyalgia, Cannabis | Phase 2 | Status: UNKNOWN